Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112670132 | 11267013 | 2 | F | 20091226 | 20151116 | 20150713 | 20160707 | EXP | US-DSJP-DSU-2015-113903 | DAIICHI | 65.80 | YR | F | Y | 72.56000 | KG | 20160707 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112670132 | 11267013 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, QD | 21532 | FILM-COATED TABLET | QD | |||||||||
| 112670132 | 11267013 | 2 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 112670132 | 11267013 | 3 | C | MELOXICAM. | MELOXICAM | 1 | 15 MG, QD | 0 | 15 | MG | QD | ||||||||
| 112670132 | 11267013 | 4 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 112670132 | 11267013 | 5 | C | ENBREL | ETANERCEPT | 1 | 25 MG, ONCE EVERY 1 WK | 0 | 25 | MG | /wk | ||||||||
| 112670132 | 11267013 | 6 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112670132 | 11267013 | 1 | Hypertension |
| 112670132 | 11267013 | 2 | Product used for unknown indication |
| 112670132 | 11267013 | 3 | Product used for unknown indication |
| 112670132 | 11267013 | 4 | Product used for unknown indication |
| 112670132 | 11267013 | 5 | Product used for unknown indication |
| 112670132 | 11267013 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112670132 | 11267013 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112670132 | 11267013 | Gastrointestinal injury | |
| 112670132 | 11267013 | Haemorrhoids | |
| 112670132 | 11267013 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112670132 | 11267013 | 1 | 20080902 | 20100214 | 0 | |
| 112670132 | 11267013 | 2 | 200905 | 0 | ||
| 112670132 | 11267013 | 3 | 200605 | 0 | ||
| 112670132 | 11267013 | 4 | 200402 | 0 | ||
| 112670132 | 11267013 | 5 | 200110 | 0 | ||
| 112670132 | 11267013 | 6 | 201003 | 0 |